Mercer Global Advisors »

4d Molecular Therapeutics In shares owned by Mercer Global Advisors

Quarter-by-quarter ownership of 4d Molecular Therapeutics In (FDMT) shares owned by Mercer Global Advisors from 13F filings

Historical chart of Mercer Global Advisors investment in 4d Molecular Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including 4d Molecular Therapeutics In held by Mercer Global Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in 4d Molecular Therapeutics In by Mercer Global Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $62k 4.7k 13.30

More positions owned by Mercer Global Advisors

Ishares Tr Core Us Aggbd Et (AGG)
Vanguard Bd Index Fds Short Trm Bond (BSV)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Dimensional Etf Trust Us Cor Equ 2 Etf (DFAC)
Ishares Tr Msci Usa Mmentm (MTUM)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Dimensional Etf Trust Us Mktwide Value (DFUV)
Dimensional Etf Trust Us High Prof Etf (DUHP)
Vanguard Charlotte Fds Total Int Bd Etf (BNDX)
Dimensional Etf Trust Intl Core Equity (DFIC)
Ishares Tr Msci Intl Moment (IMTM)
Dimensional Etf Trust Internatnal Val (DFIV)
Dimensional Etf Trust Intl High Profit (DIHP)
American Centy Etf Tr Avan Us Smal Etf (AVSC)
Ishares Tr National Mun Etf (MUB)

View all positions for Mercer Global Advisors

Top funds holding 4d Molecular Therapeutics In

Jupiter Topco
Henderson Group
RA Capital Management
BlackRock
Goldman Sachs Group
Novo A/S
BVF
State Street Corporation
Adage Capital Partners GP
Trails Edge Capital Partners
Vanguard Capital Management
Armistice Capital
Geode Capital Management
Bank of America Corporation
Evergreen Quality Fund GP

View all funds holding 4d Molecular Therapeutics In